Abstract Aims-To evaluate success in obtaining adequate bone marrow trephine biopsy cores from children. Methods-Sections of trephine biopsy cores submitted by 25 centres from children with neuroblastoma over a five year period were reviewed centrally. In cores containing no tumour adequacy was defined as 0 5 cm ofwell preserved bone marrow after processing. Occasional smaller cores containing obvious tumour were also considered adequate. Results-Of 822 biopsy specimens, 139 (17%) were inadequate. In 13 centres submitting at least 20 cores failure rates ranged from 2-6 to 50%. There was no improvement over the five years of the study. There was no practically important correlation between the numbers of cores submitted and success in obtaining adequate specimens. Although a lower rate ofinadequate biopsy specimens was found when haematologists rather than paediatricians (13 v 29%) were the predominant operators this should not be overinterpreted, not least because of the potentially confounding association between haematologist operators and larger numbers ofbiopsy specimens, and because the arbitrary subdivision of centres according to operator specialty was crude. Bone marrow trephine biopsy is an important investigation in a variety of malignant and non-malignant diseases of children.' In many centres it is carried out under a short general anaesthetic and represents a substantial, invasive investigation. The responsibility to obtain adequate samples from children is arguably even greater than in adults as children may not usually give their own consent to the procedure. Without adequate samples there is little point in performing the investigation, let alone trying to base clinical decisions on the result. There are no studies of success in obtaining interpretable biopsy cores from children but it is perceived by most to be more difficult than in adults.
necessary because this is an invasive investigation, often performed under general anaesthesia. Reporting pathologists are well placed to influence practice by pointing out inadequacies in the specimen and suggesting retraining or even a change in operator. Improvement would almost certainly occur if this investigation was restricted to locally recognised successful operators, whatever their specialty. Most centres should review their practice and devise strategies to improve their ability to obtain adequate cores. (J7 Clin Pathol 1996; 49:226-229) Keywords: bone marrow trephine biopsy, children, neuroblastoma.
Bone marrow trephine biopsy is an important investigation in a variety of malignant and non-malignant diseases of children.' In many centres it is carried out under a short general anaesthetic and represents a substantial, invasive investigation. The responsibility to obtain adequate samples from children is arguably even greater than in adults as children may not usually give their own consent to the procedure. Without adequate samples there is little point in performing the investigation, let alone trying to base clinical decisions on the result. There are no studies of success in obtaining interpretable biopsy cores from children but it is perceived by most to be more difficult than in adults.
As part of a European Neuroblastoma Study Group trial, bone marrow trephine biopsy specimens obtained in individual participating centres were reviewed centrally. This multicentre study afforded the unique opportunity to examine a large number of biopsy cores from children and assess ability to obtain adequate specimens. Other issues, such as review of the histological opinions and the putative clinical importance of the investigation, are specifically relevant to the management of neuroblastoma and will be addressed later.
Methods
The study ran from January 1990 to December 1994. Sections of bone marrow biopsy cores stained with haematoxylin and eosin or Giemsa (and often with a silver stain for reticulin) were reviewed by both authors. Each biopsy was assessed for adequacy. In the absence of any published guidelines on biopsy size in children when this bone marrow biopsy review started, adequacy was, in the main, based on the opinion of the two central reviewers and sections containing less than 0 5 cm of well preserved bone marrow (as opposed to bone or cartilage) were considered inadequate. Because the original purpose was to review the staging and response to treatment in children with neuroblastoma, some smaller portions were also considered adequate if they contained obvious tumour. Next, inadequate biopsy rates were correlated with the year of biopsy (in case there had been any change over time), with the total number of cores submitted by individual centres (as a crude surrogate for the frequency with which children's bone marrow was biopsied at each centre) and with the specialty and grade of the operator who usually obtained them. For this last purpose, four main subgroups were used: each centre described its usual operator as consultant paediatric oncologist (or other career grade), trainee paediatric oncologist, consultant haematologist, trainee haematologist, or combinations of these. The specialty of the predominant op- erator for each centre (haematologist, paediatrician, or both, of whatever grade) was assigned by assuming that each usual operator within one centre carried out roughly equal numbers of biopsies. Confidence intervals were obtained from standard tables (Documenta Geigy, Scientific Tables).
Results
In total, 822 bone marrow trephine biopsy specimens from 186 children submitted by 25 centres were reviewed. The number submitted by individual centres ranged from three to 84. In total, 139 (17%) were considered inadequate for meaningful evaluation. There are no data on attempted biopsies which yielded no specimen or numbers of attempts required to obtain the submitted specimen. Table 1 shows the rate of inadequate biopsy specimens for each of the five years. There is no trend towards increasing success with time. Table 2 shows the rate of inadequate biopsy specimens from all 25 centres together with the specialty and grade of each centre's usual operators and the specialty of the predominant operator. There is no striking, or clinically important, correlation between inadequate biopsy rates and number of biopsy specimens submitted by the 25 centres. Thirteen centres submitted at least 20 cores, with inadequacy rates ranging from 2-6 to 50%. Only three centres had no inadequate cores, but all had sent less than 10 for review. Only four centres had permanent, career grade paediatricians among the usual operators, and all submitted less than 20 biopsy specimens. Six centres had consultant haematologists among the usual operators, five of whom submitted more than 20 biopsy specimens. There were only three centres in which trainees in one or the other specialty were not among the usual operators. Table 3 shows the relation among specialty of predominant operators, overall inadequate biopsy rate for that specialty and mean number of biopsy specimen submitted per centre in each group. Because of a pre-existing bias on the part of one reviewer' and some data obtained from adults2 suggesting that haematologists might be more successful in obtaining adequate specimens, results from nine centres in which haematologists were the predominant operators, 11 in which paediatricians usually obtained the specimens and the remaining five were put into separate groups. Superficially, haematologists seemed to be more successful (inadequate biopsy rate 13%) than paediatricians (29%). The results from the group in which both specialties were usually involved were similar to those of the haematologists, but one (centre 4 in table 2) stood out as being very successful in obtaining good sized, untraumatised, interpretable cores. However, with results grouped in this way, numbers of biopsy specimens could be a confounding factor; the 11 centres in which haematologists played little part also submitted the least number of biopsy specimens.
Thirty of the cores were taken from anterior as opposed to posterior iliac crests. Only three were inadequate. However, two thirds of these anterior crest biopsy specimens were submitted by a single centre. It is not possible to comment on any relation between site of biopsy and failure rate.
Discussion
Systematic study of the adequacy of bone marrow trephine biopsy specimens has been carried out rarely in adults and never in children. One small study compared various methods of examining the marrow of children and seemed to prefer buffy coat preparations of aspirated bone marrow to biopsy specimens,' but did not assess adequacy of the biopsy specimen. In the main, adequacy of the biopsy specimen is a matter of the opinion of the reporting pathologist and will depend on an assessment of quantities of bone and cartilage, degree of trauma, quality of fixation, and other features, among which is the length of interpretable marrow core. A large study from the Christie Hospital, Manchester,2 demonstrated wide variation in the length of untraumatised, evaluable bone marrow present in biopsy cores from adults. They derived the average length of the biopsy specimen beyond which the rate of detecting infiltrates did not increase. They found that the minimum acceptable average length was 0-8 cm of bone marrow after processing (obtained from a total core length of 1 6 cm containing 1 l cm of marrow before processing).
It may be unrealistic to expect that similarly long cores could routinely be obtained in children, and the largest bore needles used in adults are often inappropriate in small children. Recent recommendations for investigation of bone marrow in children with neuroblastoma4 contain the arbitrary suggestion that a core of marrow, not bone or cartilage, at least 1 cm long before processing (roughly equivalent to 0 75 cm of bone marrow in the section after the shrinkage caused by processing2) should be the target at the bedside. This begs the question that the operator can distinguish bone/cartilage from marrow in a freshly obtained sample, a task which requires experience in the operator and feed-back from the reporter of the biopsy specimen. The present review of bone marrow biopsy cores began well before either the Christie Hospital's study or the revised international recommendations were published. We were less demanding in our criteria of adequacy (in so far as length of biopsy specimen is concerned) at the start of this study, retained the same criteria throughout and also acknowledge additional overestimation of success rates by including among the adequate biopsy specimens some smaller cores which contained obvious tumour. Whatever length of core is considered optimal, determining the amount of well preserved marrow will remain a matter of judgement on the part of the reporting pathologist and is not readily amenable to measurement. In centrally reviewed studies there is less variation in that judgement, but the reviewers may be more or less demanding than many local reporters.
Despite potential criticism of the arbitrary definition of adequacy which restricted inadequate biopsy specimens to those with less than 0 5 cm of interpretable bone marrow after processing (roughly equivalent to 0-7 cm of marrow before the shrinkage induced by processing2), 17% of cores were inadequate. This rate would have been higher if the Christie Hospital's criteria of adequacy in adults or the arbitrary revised international recommendations had been available and applied in the review process at the outset. The most striking feature was the great variation in rates of inadequate biopsy specimens between individual centres, ranging from less than 3 to 50% in those 13 submitting at least 20 cores. Three centres in all seemed to be highly successful. However, if the figures for the remaining 10 are also representative of diseases other than neuroblastoma, a substantial number of children may currently undergo an invasive but unfruitful or potentially misleading investigation. In view of the relatively undemanding criteria of adequacy we used, it seems unlikely that we have exaggerated the size of the problem.
Many children in the present series had two biopsy specimens taken on each occasion because this was requested by the study protocol. The sum of two marrow cores may provide as much information as a single, longer core, although this has not been formally established. If this is indeed the case, it strengthens the argument for two trephine biopsy specimens in children, unless a core with at least 0-8 cm of bone marrow after processing can be obtained, whatever the underlying disease. Too few infants were included in this study to analyse adequacy of biopsy specimens for this group. The particular issue of minimum acceptable length of bone marrow core in neuroblastoma is beyond the scope of this study. Biopsy specimens were obtained both at presentation and at varying intervals after treatment had started. The small number of cores in this series without detectable infiltration at presentatiorn and a steadily declining level of infiltration after treatment (data not shown) introduce complexities which make the Christie Hospital's approach to defining adequacy potentially inappropriate for neuroblastoma and unsuitable for extrapolation from neuroblastoma to other children's diseases.
There was no evidence of improvement over the five years of this study. The apparent fall in the rate of inadequate biopsy specimens between 1993 and 1994 (to the level observed in 1991) may be no more than chance. It is too early to ascribe it to the 1993 recommendations4 or the results of the Christie Hospital's study, published in late 1992,2 although both may have some impact in due course. Carrying out larger numbers ofbiopsies did not, per se, ensure a higher success rate in an individual centre. Even if there were a trend there would be little case for further centralising this investigation to fewer and larger centres. It should be remembered that a surrogate for the number of biopsies in all children per centre, rather than the actual number, was used. Any effect of numbers of biopsies is thus of little practical importance.
The relation between specialty of the predominant operator and success rate shown in table 3 seems to suggest that haematologists are more successful than paediatric oncologists at obtaining adequate biopsy specimens, a conclusion similar to that found in adults in the Christie Hospital's study.2 However, this conclusion is based upon relatively crude generalisations about each centre's usual practice and takes no account of the lack of data on complete failure to obtain a core or of persistence and skill of individual operators, variable numbers of biopsy specimens on each occasion and technical problems unique to individual patients. Attempts to identify too precisely, from the data in this study, which of the crudely measured (or unmeasured) factors are most important seem inappropriate. Once the centres were grouped according to the specialty of the predominant operator, the possibility of an effect ofnumbers emerged. The results from one centre in particular (centre 4, table 2) show that some paediatricians are highly successful operators, presumably because of good training and/or close contact between operators and those who report the biopsy specimens.
Consultant or other permanent, career grade paediatricians were rarely among the usual operators in the centres involved in this study, and then only in those that had submitted fewer than 20 cores. The major workload was carried by trainees, both haematologists and paediatric oncologists. However, as a general policy, training junior paediatricians to carry out this procedure seems to lack purpose unless future generations of paediatric oncologists alter their practice and continue to perform bone marrow biopsies once they have become consultants. The performance of trainees in both specialties should be closely monitored.
As the Christie Hospital's experience shows, those who report bone marrow trephine biopsy specimens are well placed to influence the operator.2 Improvement may follow ifpathologists regularly point out deficiencies in the quality of the specimens and offer congratulations when the specimen is of high quality. This should encourage the professional pride of the operator to flourish but requires direct communication with operators, rather than simply sending a typed report. In retrospect, although it was not formally determined, an important cause of inadequacy in this series was lack of bone marrow despite substantial amounts of bone or cartilage. Retraining operators to distinguish one from the other might be profitable. Retraining need not be restricted to clinically indicated bone marrow biopsies; in suitable circumstances experience may be acquired during postmortem examinations. Although a young child's iliac crest may feel different from that of an older patient, the experience which can be gained by biopsying adults should not be ignored. Results would almost certainly improve if the procedure were restricted to locally recognised successful operators, whatever their specialty.
The results of this study suggest that most centres that perform bone marrow trephine biopsies in children should review their practice and, where necessary, make attempts to improve adequacy of the biopsy cores. This recommendation should probably be extended to the whole range of diseases in which bone marrow biopsy is an important investigation. There are several options: increase the proportion of biopsies performed by haematologists (not always easy to achieve in some centres, unnecessary in others); retrain less successful operators; concentrate on successful operators; and improve feed back about biopsy quality or devise a unique blend ofthese options according to specific circumstances.
